Gene · 2739
Papers2,767
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,767
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Validating core therapeutic targets for osteoporosis treatment based on integrating network pharmacology and informatics. | SLAS Technol | 2024 | 38364892 | PubTator, text mining | PubMed |
| Unraveling Potential Glyoxalase-I Inhibitors Utilizing Structure-Based Drug Design Techniques. | Adv Appl Bioinform Chem | 2024 | 38343400 | PubTator, text mining | PubMed |
| Genetic Association Studies in Restless Legs Syndrome: Risk Variants & Ethnic Differences. | Can J Neurol Sci | 2024 | 38267254 | PubTator, text mining | PubMed |
| Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential. | Int J Mol Sci | 2024 | 38255791 | PubTator, text mining | PubMed |
| Computational fragment-based drug design of potential Glo-I inhibitors. | J Enzyme Inhib Med Chem | 2024 | 38247330 | PubTator, text mining | PubMed |
| Increased cellular protein modification by methylglyoxal activates endoplasmic reticulum-based sensors of the unfolded protein response. | Redox Biol | 2024 | 38199038 | PubTator, text mining | PubMed |
| Exogenous application of jasmonates and brassinosteroids alleviates lead toxicity in bamboo by altering biochemical and physiological attributes. | Environ Sci Pollut Res Int | 2024 | 38158528 | PubTator, text mining | PubMed |
| Pentagamavunone-1 inhibits aggressive breast cancer cell proliferation through mitotic catastrophe and ROS-mediated activities: in vitro and in vivo studies. | Saudi Pharm J | 2024 | 38146327 | PubTator, text mining | PubMed |
| A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices. | Mol Neurobiol | 2024 | 37980327 | PubTator, text mining | PubMed |
| The PKM2 inhibitor shikonin enhances piceatannol-induced apoptosis of glyoxalase I-dependent cancer cells. | Genes Cells | 2024 | 37963646 | PubTator, text mining | PubMed |
| Protein glycation: a wolf in sweet sheep's clothing behind neurodegeneration. | Neural Regen Res | 2024 | 37862195 | PubTator, text mining | PubMed |
| The effect and mechanism of Fushen Granule on gut microbiome in the prevention and treatment of chronic renal failure. | Front Cell Infect Microbiol | 2023 | 38274729 | PubTator, text mining | PubMed |
| Genomic analysis identifies risk factors in restless legs syndrome. | medRxiv | 2023 | 38168192 | PubTator, text mining | PubMed |
| Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion. | iScience | 2023 | 38162029 | PubTator, text mining | PubMed |
| Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles. | Front Mol Biosci | 2023 | 38099195 | PubTator, text mining | PubMed |
| Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies. | Molecules | 2023 | 38067472 | PubTator, text mining | PubMed |
| Association between GLO1 variants and gestational diabetes mellitus susceptibility in a Chinese population: a preliminary study. | Front Endocrinol (Lausanne) | 2023 | 38027126 | PubTator, text mining | PubMed |
| Renoprotective Potency of Sitagliptin versus Pioglitazone in Type 2 Diabetic Patients: Impact on LncMIAT. | ACS Omega | 2023 | 38024775 | PubTator, text mining | PubMed |
| INPP5D regulates inflammasome activation in human microglia. | Nat Commun | 2023 | 38016942 | PubTator, text mining | PubMed |
| Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma. | Aging (Albany NY) | 2023 | 38015710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2739/papers?page=7